Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2
Whiteside, T.L.; Heo, D.S.; Chen, K.; Adler, A.; Johnson, J.T.; Herberman, R.B.
Progress in Clinical and Biological Research 244: 213-222
1987
ISSN/ISBN: 0361-7742 PMID: 3309998 Document Number: 294096
Document emailed within 1 workday
Related Documents
Itoh, K.; Shiiba, K.; Ebina, N.; Anzai, R.; Ouchi, A.; Matsuno, S. 1993: Functional and phenotypic analysis of tumor infiltrating lymphocytes derived from solid tumors and effusion associated lymphocytes in malignant ascites cultured in recombinant interleukin 2 Nihon Geka Gakkai Zasshi 94(8): 781-790Miescher, S.; Whiteside, T.L.; Moretta, L.; von Fliedner, V. 1987: Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors Journal of Immunology 138(11): 4004-4011
Bukowski, R.M.; Sharfman, W.; Murthy, S.; Rayman, P.; Tubbs, R.; Alexander, J.; Budd, G.T.; Sergi, J.S.; Bauer, L.; Gibson, V. 1991: Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma Cancer Research 51(16): 4199-4205
Zhang, Y.-X.; Wang, X.-Y.; Liu, J.-B.; Zhang, S.-Q.; Chen, Y.-R. 2008: Effects of auto-tumor infiltrating lymphocytes induced by interleukin (IL)-12 with IL-2 on patients of primary hepatic carcinoma Zhonghua Yi Xue Za Zhi 88(14): 973-976
Steiner, T.; Junker, U.; Wunderlich, H.; Schubert, J. 1999: Are renal cell carcinoma cells able to modulate the cytotoxic effect of tumor infiltrating lymphocytes by secretion of interleukin-6? Anticancer Research 19(2c): 1533-1536
Lissoni, P.; Rovelli, F.; Tisi, E.; Brivio, F.; Ardizzoia, A.; Barni, S.; Tancini, G.; Saudelli, M.; Cesana, E.; Viganò, M.G. 1995: Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors Journal of Biological Regulators and Homeostatic Agents 9(4): 146-149
Liao, G.; Mao, Z.; Xu, P. 1998: Inhibition effects of tumor infiltrating lymphocytes from oral cancer on nude mice transplanted tumor established with human tongue carcinoma cell lines Zhonghua Kou Qiang Yi Xue Za Zhi 33(3): 146-148
Sekine, T.; Kakizoe, T.; Tobisu, K.; Takai, K.; Tanaka, Y.; Makuuchi, M.; Takayama, T. 1989: Cultivation of human tumor infiltrating lymphocytes for use in adoptive immunotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-2): 1469-1473
Vose, B.M.; Moore, M. 1985: Human tumor-infiltrating lymphocytes: a marker of host response Seminars in Hematology 22(1): 27-40
Topalian, S.L.; Solomon, D.; Rosenberg, S.A. 1989: Tumor-specific cytolysis by lymphocytes infiltrating human melanomas Journal of Immunology 142(10): 3714-3725
Kang, S.; Shen, K.; Lang, J. 1998: The comparison of biological characteristics between tumor-infiltrating lymphocytes and tumor-associated lymphocytes in ascites of epithelial ovarian carcinoma Zhonghua Fu Chan Ke Za Zhi 33(10): 607-610
Chin, Y.; Janseens, J.; Vandepitte, J.; Vandenbrande, J.; Opdebeek, L.; Raus, J. 1992: Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer Anticancer Research 12(5): 1463-1466
Gillies, S.D.; Wesolowski, J.S.; Lo, K.M. 1991: Targeting human cytotoxic T lymphocytes to kill heterologous epidermal growth factor receptor-bearing tumor cells. Tumor-infiltrating lymphocyte/hormone receptor/recombinant antibody Journal of Immunology 146(3): 1067-1071
Giacchi, R.; Sebastiani, M.; Canestrari, F.; Di Quirico, M.; Lungarotti, F. 1987: Solid tumors and enzyme activity in human lymphocytes Italian Journal of Surgical Sciences 17(4): 295-299
Cole, D.J.; Wilson, M.C.; Rivoltini, L.; Custer, M.; Nishimura, M.I. 1997: T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes Cancer Research 57(23): 5320-5327
Hori, T.; Kan, N.; Ohgaki, K.; Yamazaki, N.; Nakayama, N.; Nio, Y.; Inamoto, T. 1984: Tumor-specific cytotoxicity of tumor infiltrating lymphocytes (TIL) induced with TCGF in murine mammary carcinoma Nihon Geka Gakkai Zasshi 85(8): 749-757
Kierszenbaum, F.; Lopez, H.M.; Sztein, M.B. 1996: Trypanosoma cruzi downregulates the production of interleukin-2, interferon-gamma, interleukin-4 and interleukin-5 by activated human lymphocytes Journal of Parasitology 82(4): 652-656
Choudhary, A.; Davodeau, F.; Moreau, A.; Peyrat, M.A.; Bonneville, M.; Jotereau, F. 1995: Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma Journal of Immunology 154(8): 3932-3940
Coventry, B.J.; Weeks, S.C.; Heckford, S.E.; Sykes, P.J.; Bradley, J.; Skinner, J.M. 1996: Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers Journal of Immunology 156(9): 3486-3492
Möller, P.; Wittig, B.; Schadendorf, D. 1998: Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report Anticancer Research 18(2b): 1237-1241